Skip to content

Clinical trials

Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20063
20091
20103
20113
20122
20133
20142
20154
20162
20178
20183
20193
20206
20212
20223
20234
20246
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting12
Terminated10
Unknown status8
Withdrawn3
Not yet recruiting2
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Protara Therapeutics4
CG Oncology, Inc.3
M.D. Anderson Cancer Center3
Bayer2
Bioniche Life Sciences Inc.2
Children's Oncology Group2
Endo USA Inc., a Keenova Therapeutics Company2
National Cancer Institute (NCI)2
Newish Technology (Beijing) Co., Ltd.2
University of Pittsburgh2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ70
Urinary Bladder Neoplasms24
Non-Muscle Invasive Bladder Neoplasms18
Neoplasms15
Carcinoma, Transitional Cell10
Uterine Cervical Neoplasms8
Breast Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Uterine Cervical Dysplasia6
Barrett Esophagus3

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.